MedTrace Logo

Cefaly® Device in the Treatment of Patients With Fibromyalgia.

NCT02546362 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-07-19

Study results available
· View outcomes & findings →

Summary

The objective of this pilot open trial was to assess the efficacy and safety of external trigeminal nerve stimulation (e-TNS) with the Cefaly® device in fibromyalgia.

Conditions

  • Fibromyalgia

Interventions

DEVICE

Cefaly

Sponsors & Collaborators

  • Cefaly Technology

    lead INDUSTRY

Principal Investigators

  • Lesley Arnold, M.D. · University of Cincinnati

  • Pierre Rigaux · Cefaly Technology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-03
Primary Completion
2018-05-15
Completion
2018-05-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02546362 on ClinicalTrials.gov